Target Price | $11.22 |
Price | $0.94 |
Potential |
1,093.74%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target GT Biopharma Inc 2026 .
The average GT Biopharma Inc target price is $11.22.
This is
1,093.74%
register free of charge
$11.55
1,128.85%
register free of charge
$11.11
1,082.04%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend GT Biopharma Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the GT Biopharma Inc stock has an average upside potential 2026 of
1,093.74%
register free of charge
|
Analyst | Rating | Action | Date |
---|---|---|---|
Roth MKM |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
Analyst Rating | Date |
---|---|
Locked
Roth MKM:
Locked
➜
Locked
|
Dec 02 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.